Clexio Biosciences

Clexio Biosciences is a multi-asset, central nervous system-first clinical stage pharmaceutical company with a broad and growing pipeline, dedicated to developing novel therapies for patients suffering from neurological and psychiatric conditions. One of the company’s driving principles is to invent new therapeutic modalities and bring them quickly from an idea to proof of concept and then to full clinical development, identifying points of convergence between validated mechanisms of action and technology to generate new patient-centric possibilities.